Oral Pyridorin (pyridoxamine) - NephroGenex
NephroGenex: Q1 2015 Results (Nephrogenex) - May 18, 2015 - Anticipated completion of enrollment of 600 patients in P3 PIONEER trial (NCT02156843) for diabetic nephropathy in H1 2016 
Anticipated enrollment status • Diabetic Nephropathy • Renal Disease
http://seekingalpha.com/article/3182696-nephrogenexs-nrx-ceo-pierre-legault-on-q1-2015-results-earnings-call-transcript
 
May 18, 2015
 
.